Journal article
Interaction Between Digoxin and Dronedarone in the PALLAS Trial
Abstract
BACKGROUND: Elevated serum digoxin concentration can cause toxicity, including death. Dronedarone increases digoxin concentration by P-glycoprotein interaction. In Permanent Atrial Fibrillation Outcome Study Using Dronedarone On Top Of Standard Therapy Trial (PALLAS), dronedarone was associated with both increased cardiovascular death and heart failure in patients with permanent atrial fibrillation. The present analysis examines whether the …
Authors
Hohnloser SH; Halperin JL; Camm AJ; Gao P; Radzik D; Connolly SJ
Journal
Circulation Arrhythmia and Electrophysiology, Vol. 7, No. 6, pp. 1019–1025
Publisher
Wolters Kluwer
Publication Date
December 2014
DOI
10.1161/circep.114.002046
ISSN
1941-3149
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
AgedAged, 80 and overAmiodaroneAnti-Arrhythmia AgentsAtrial FibrillationCardiotonic AgentsCause of DeathDigoxinDouble-Blind MethodDronedaroneDrug InteractionsDrug MonitoringDrug Therapy, CombinationElectrocardiographyFemaleHeart FailureHumansKaplan-Meier EstimateMaleProportional Hazards ModelsRisk FactorsTime FactorsTreatment Outcome